Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long Covid

SGTC Research Conference Includes Focus On ME / CFS

 #OMFScienceWednesday share the highlights from this week’s Stanford Genome Technology Center (SGTC) research conference, an annual event where Dr. Ron Davis’ team assembles to share their results and discuss the future of their research. An entire session was dedicated to ME / CFS research, with additional sessions on SGTC’s core work in synthetic biology, genomics approaches to disease, and diagnostic technologies.

During the ME / CFS session, there were updates on the Severely Ill Patient Study, funded by OMF. Wenzhong Xiao, PhD, showed that: 1) SF-36 scores are worse in ME / CFS than several major diseases and correlate the least with depression and mental illnesses; 2) 21 cytokines are different between ME / CFS patients and controls; 3) 27 clinical tests are different between patients and controls, including low morning cortisol in patients; 4) 63 metabolites are different between patients and controls; and 5) ME / CFS bears strong similarities to systemic inflammatory response syndrome.

This is a massive dataset that offers many additional opportunities for analysis. Several ideas were discussed at the conference’s breakout sessions, including how to apply mathematical modeling, genetic analysis, comparing to other diseases, and more. The full dataset is being opened up to the research community to accelerate these efforts! Check out the full list of tests that were run in this study: /phase-i-list-of-tests/

Laurel Crosby, PhD, pointed out how far the ME / CFS research at SGTC has come thanks to the support of OMF: from just one patient and no funding a few years ago, to dozens of patients, numerous new datasets, a rich network of collaborators, and funds for both personnel and experiments. The whole team is so grateful for this support and the scientific possibilities it offers!

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669